Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Reducing Obesity and Type 2 Diabetes in High Risk Youth

Phase 2

Completed

Conditions: Obesity
Type 2 Diabetes

Interventions: Behavioral: HEALTH[e]TEEN
Behavioral: HEALTH[e]TEEN + CST

First Posted Date: 2012-03-22

Last Posted Date: 2012-03-22

Lead Sponsor: Yale University

Target Recruit Count: 384

Registration Number: NCT01560676

Locations: 🇺🇸
Yale, New Haven, Connecticut, United States

FMRI of Stress and Addictive Disorders

Completed

Conditions: Cocaine Dependence
Opioid Dependence
Alcoholism
Pathological Gamblers
Adolescents

First Posted Date: 2012-03-20

Last Posted Date: 2016-11-30

Lead Sponsor: Yale University

Target Recruit Count: 108

Registration Number: NCT01558973

Locations: 🇺🇸
Yale Stress Center, New Haven, Connecticut, United States

Testing and Linkage to Care for Injecting Drug Users in Kenya

Not Applicable

Completed

Conditions: HIV Infection
HCV Coinfection

Interventions: Behavioral: POC CD4 and Peer Case Management
Drug: HCV+PWID
Behavioral: Control - No intervention

First Posted Date: 2012-03-20

Last Posted Date: 2018-10-05

Lead Sponsor: Yale University

Target Recruit Count: 9449

Registration Number: NCT01557998

Locations: 🇰🇪
National AIDS/STD Control Programme (NASCOP), Nairobi, Kenya

Internet Treatment for Weight Loss in Primary Care

Not Applicable

Completed

Conditions: Overweight
Obese

Interventions: Behavioral: Motivational Interviewing
Behavioral: Treatment as usual with primary care physician
Behavioral: Nutritional Counseling

First Posted Date: 2012-03-20

Last Posted Date: 2015-07-01

Lead Sponsor: Yale University

Target Recruit Count: 89

Registration Number: NCT01558297

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease

Not Applicable

Completed

Conditions: Steatohepatitis
Hypertriglyceridemia
Non Alcoholic Fatty Liver Disease
Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1

Interventions: Other: Omega diet

First Posted Date: 2012-03-16

Last Posted Date: 2017-04-28

Lead Sponsor: Yale University

Target Recruit Count: 17

Registration Number: NCT01556113

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

The Role of Stress in Self-Control, Coping, and Emotion Regulation

Completed

Conditions: Stress

First Posted Date: 2012-03-15

Last Posted Date: 2016-11-30

Lead Sponsor: Yale University

Target Recruit Count: 855

Registration Number: NCT01554501

Locations: 🇺🇸
Yale Stress Center, New Haven, Connecticut, United States

Varenicline Treatment of Alcohol Dependence in Smokers

Phase 2

Completed

Conditions: Alcoholism
Alcohol Abuse
Smoking
Alcohol Drinking

Interventions: Drug: Varenicline

First Posted Date: 2012-03-13

Last Posted Date: 2020-03-06

Lead Sponsor: Yale University

Target Recruit Count: 131

Registration Number: NCT01553136

Locations: 🇺🇸
Connecticut Mental Health Center - Substance Abuse Treatment Unit, New Haven, Connecticut, United States
🇺🇸
Parallax Center, New York, New York, United States

Ketamine for Depression and Alcohol Dependence

Phase 1

Completed

Conditions: Depression
Alcohol Dependence

Interventions: Drug: Ketalar (ketamine)

First Posted Date: 2012-03-12

Last Posted Date: 2020-03-09

Lead Sponsor: Yale University

Target Recruit Count: 5

Registration Number: NCT01551329

Locations: 🇺🇸
VA CT Healthcare Systems, West Haven, Connecticut, United States

HIV, Buprenorphine, and the Criminal Justice System

Not Applicable

Completed

Conditions: Opiate Addiction
Human Immunodeficiency Virus
Acquired Immunodeficiency Syndrome
Drug Dependence

Interventions: Drug: Buprenorphine/naloxone
Drug: Placebo Oral Tablet

First Posted Date: 2012-03-12

Last Posted Date: 2020-05-06

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT01550341

Locations: 🇺🇸
Howard University, Washington, District of Columbia, United States

Guanfacine in Children With Tic Disorders

Phase 4

Completed

Conditions: Tourette Disorder
Tourette Syndrome

Interventions: Drug: placebo
Drug: extended-release guanfacine (Intuniv)

First Posted Date: 2012-03-07

Last Posted Date: 2021-08-13

Lead Sponsor: Yale University

Target Recruit Count: 34

Registration Number: NCT01547000

Locations: 🇺🇸
University of South Florida, Tampa, Florida, United States
🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy